Spark Therapeutics
Spark Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. It is pioneering one-time treatments targeting inherited retinal disorders, hemophilia, and neurodegenerative conditions using proprietary AAV vector technology. It is a subsidiary of Roche.
Address: 3737 Market Street, Suite 1300, Philadelphia, PA 19104
Phone: 1‑855‑SPARKTX (855) 772‑7589 or (215) 220-9300
-
Here’s How Pennsylvania Can Unlock Its Potential to Become a True Economic Leader
Pennsylvania companies are changing the world. It’s on us to support them and their workers and create opportunities for more to thrive. Spark Therapeutics in…
-
Former CEO Shares Thoughts on How Gov. Shapiro Can Boost PA’s Innovation Economy
Jeff Marrazzo, the former CEO of Philadelphia-based Spark Therapeutics and a member of the innovation subcommittee of Gov. Josh Shapiro’s transition team, has several ideas…
-
Two Chester County Pharmacueticals to be Honored by PABIO
On Monday, Pennsylvania Bio, the voice of advancement for Pennsylvania’s Bioscience Industry, announced the winners of two of its major awards that are named after…
-
Pennsylvania Bio Will Honor Top Doctor, CEO At Upcoming Annual Dinner
Dr. Carl H. June of the University of Pennsylvania and Dr. Jeffrey Marrazzo, co-founder and CEO of Spark Therapeutics, will receive top honors from Wayne-based…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
